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1. Introduction 
Although the comorbidity issues in psychiatry have received a wide recognition for at least 
the last 20 years and caused a great stream of publications all over the world, many 
questions remain unanswered. It concerns as phenomenon of comorbidity itself, as plausible 
explanation of its origin. Little is known, why in some patients the so-called pure (non 
comorbid) psychopathological states present (i.e. pure depression or anxiety), while in other 
cases comorbidity between affective and anxiety disorders exists. At present, factors 
determining the comorbidity between depression and anxiety disorders unfortunately 
remain unknown.  
The principal and unexplained phenomenon in comorbidity issues concern the asymmetry 
in comorbidity between affective and anxiety disorders (Table 1). Indeed, patients with 
primary diagnosis of anxiety disorder have more frequent comorbidity with depression (48-
62%) than vice versa (10-20%, Table 1).  (Kendler et al., 1992; Kessler, 1999; Kessler et al., 
1994; 1995; 1996, 1999; Roy-Byrne et al., 2000).  
These findings haven’t obtained any plausible explanation yet, and comorbidity studies 
including description of comorbid disorders and statistical evaluation of risk for their 
development didn’t give us any clue (except for genetic origin or predisposing trigger 
factors) for solving these issues.   
On the other hand, neuropsychological or neuropsychiatric mechanisms have been rarely 
used in order to explain any psychopathological phenomena, and strong demarcation line, 
unfortunately still exists between neuropsychology and general psychopathology, although 
the both disciplines represent two domains of neuroscience.  It concerns the problems of 
localization and lateralization of cerebral functions as in so-called normal, as in pathological 
states, although a great progress has been achieved for the last forty years in realms relevant 
to these problems. Moreover, epilepsy (especially temporal lobe epilepsy, TLE) seems to 
represent a useful model for profound understanding of unresolved psychopathological 
issues, including comorbidity between anxiety and depression. 
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In the present article an attempt has been made on suggestion one of possible mechanisms 
for comorbidity development based on neuropsychiatric and evolutionary data, although 
suggested paradigm, may be criticized and appraised rather as speculative due the lack of 
direct and strong evidence based data relevant  strictly to comorbidity of affective and 
anxiety disorders. 
2. The prevalence of affective and anxiety disorders and asymmetry in their 
comorbidity  
The principal fact should be stressed, that in general population affective disorders in form 
of depression occur more frequently than anxiety disorders (Table 2).  
 
AD 
Prevalence 
in population
Probability for
coincidence  
with MDD 
Comorbidity1 
(of MDD 
with AD) 
Comorbidity2 
(of AD 
with MDD) 
Ratio of Co-
moridity1 to 
probability for 
coincidence
Ratio of Co-
moridity2 to 
probability for 
coincidence 
PD 3,4% [2] 0,58% 
9,9% 
[21,24]
55,6% 
[2]
17,1 95,9 
GAD 
4 - 6% 
[44, 45] 
0,68-1,02% 17,2% [21,24] 
62% 
[17, 21,22]
16,9 - 25,3 60,8 - 91 
PTSD 
1,3 -8,4% 
[45] 
0,22- 1,42% 19,5% [21,24] 48% [23,24] 13,7 - 88,6 33,8 - 218 
Notes: the lifetime prevalence of MDD according to data by Blazer et al. (1994) consists 16,9%. 
Comorbidity 1 implies the primary diagnosis of MDD; Comorbidity 2 – the primary diagnosis of AD. 
Table 1. Asymmetry in comorbidity between depression and anxiety, lifetime comorbidity 
of MDD with AD, and lifetime co-morbidity of AD with MDD and calculated variables for 
co-morbidity probability 
Ratios of Comorbidity 1 and Comorbidity 2 to probability for chance expectation show the 
magnitude of comorbidity level relatively to chance coincidence.  
The data on prevalence of affective disorders and anxiety are well 
known and have been reported in numerous publications performed mostly by Kessler 
(1999) and Kessler et al.(1994; 1995; 1996, 1999). The principal data on comorbidity of 
affective and anxiety disorders are listed in the table 1. This table has been created based on 
literature findings relevant to prevalence of depression and anxiety and their concomitant 
existence in general population (Eaton et al., 1994; Kessler, 1999; Kessler et al., 1994, 1995, 
1996, 1999; Judd et al., 1998). 
 
Authors 
 
Amount of 
studied patients 
Prevalence of 
affective  
disorders (%) 
Prevalence of 
anxiety  
disorder (%) 
Significance of 
discrepancies 
Strine et al., 2005 30018 15,5% 6,8% р=0,00001 
Tellez-Zenteno 
&Wiebe, 2005 
36984 10,8% 4,7% р=0,00001 
Kobau et al., 2006 4151 15% 15% n.s. 
Total 71153 13,8% 8,8% р=0,00001 
Table 2. Comparison of prevalence of affective (depressive) and anxiety disorders in general 
population  
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As can be seen from table 1 there are certain discrepancies in variables “Comorbidity 1” and 
“Comorbidity 2”: the “Comorbidity 1” is 2 – 5,5 fold lower, then “Comorbidity 2” level. In 
other words, the primary and main diagnosis of MDD has caused lower level of 
comorbidity with any AD, while the primary diagnosis of AD has lead to higher level of 
comorbidity with MDD, and the last category seems to be more consistently present in 
comorbid pairs, than AD. These data were firstly revealed by Kessler (1999) and depression 
itself seems to be more universal and frequent phenomenon in comorbidity than anxiety. At 
the first glance the cause for such discrepancy remains unclear, although such an 
asymmetry may be explained partly by more frequent occurrence of pure depressive 
disorders compared with pure anxiety disorders, and data depicted in tables 2, as a rule, 
confirm this suggestion. 
A genetic loading alone isn’t able explain such an asymmetry in comorbidity. If anxiety and 
depression were regarded as manifestations of one disease with shared genetic inheritance 
in such a case there could be a symmetry in comorbidity between them and level of 
comorbidity should approach at least to 1,0 (100%), but this isn’t the case.  
On the other hand, depression and anxiety can’t be regarded as independent phenomena 
since in this case the comorbidity level should be much lower (as can be seen in second 
column) than the real data on comorbidity between them.  
The question on a temporal sequence in the development of MMD and AD hasn’t also 
received a proper answer, although it seems to be the principal one. Once again we aren’t 
able to explain the real level and asymmetry in comorbidity dependent on main and 
primary diagnosis. The psychodynamic point of view has been proposed by Wittchen et al. 
(1994, 2003). According to this scheme, depression develops as secondary disorder to 
primary anxiety disorder. The last has appeared earlier than former and plays a causal role 
for depression development. Although such an opinion has become a dominant and 
widespread, the mentioned model has been obtained mainly on patients with social anxiety 
and simple phobia, while data on persons with PD or GAD can’t be incorporated in 
aforementioned scheme, because these anxiety disorders are thought to appear in later age 
(Wittchen et al., 1994; 2003; Baldwin, 2003; Baldwin & Polkinghorn, 2005). It concerns 
particularly GAD, which age at onset is believed to be at average between 35 and 45 years 
(Baldwin, 2003; Baldwin & Polkinghorn, 2005). On the other hand, an average age at onset 
for recurrent depression seems to be younger, and in the Epidemiologic Catchment Area 
Study has been shown that in subjects who developed a major depressive episode, 20% had 
initial symptoms by age 19 and subsequently developed a major depressive episode by age 
25, while 50% showed depressive features by age 26 and developed depressive episode by 
age 39 (Rehm et al., 2004).  The age of onset for panic disorder, as a rule, coincident with 
major depression and seems to be in interval between middle to late 20 years (Anderson et 
al.,1984; Rapee, 1985; Rapee & Barlow, 2004). 
Moreover, the so-called simple and social phobia may be regarded as features in the frame 
of premorbid personality in persons with prevailed anxiety and obsessions. In this context 
suggestion could be made that such premorbid personality with excessive worries and sense 
of debt is very similar to Typus melancholicus described by Tellenbach (1971). This 
personality structure is thought to be a risk factor for sequential development of MDD, 
although not all studies could confirm this rule. 
Obviously the mentioned above psychodynamic mechanism alone would not be enough to 
explain properly the cause of comorbidity between affective and anxiety disorders. 
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Moreover, such a possible mechanism isn’t able again to explain the asymmetry in 
comorbidity between MDD and AD. 
At last, data in last two columns (ratio of Comorbidity1 and Comorbidity 2 to values of 
probabilities for chance coincidence MDD and respective AD) show the certain 
discrepancies between these two ratios. Thus, the probability for comorbidity of primary 
MDD diagnosis with any AD in  14 - 90 times higher, while for comorbidity of any primary 
AD diagnosis with MDD in 30 -218  times higher, compared with chance expectation for two 
disorders. Once again the ratio values for Comorbidity 2 are in 3-5 times higher, than for 
Comorbidity 1. It means that in the occurrence of any AD the presence of MDD presence is 
much probable, than vice versa. In other words, in the case of primary diagnosis of any AD 
the appearance of MDD is much more inevitable than in cases of primary diagnosis of 
MDD, although the plausible explanation for such a discrepancy is still absent. Obviously 
this can be explained by earlier MDD beginning that precedes the onset of AD, but not vice 
verse.  It concerns strictly the diagnosis of GAD and in less degree the diagnosis of PD, but 
not the diagnosis of simple and social phobia that begin usually earlier than MDD (Kessler, 
1999, Wittchen et al., 2003).     
Moreover, the age at onset for MDD after primary beginning of AD is at average 11,2 years 
higher, than vice versa (i.e. if MDD precedes the onset of AD, as has been shown in National 
Comorbidity Survey (Kessler, 1999).It concerns mostly for all forms of phobias and 
Posttraumatic stress disorder, but not PD and GAD (Kessler, 1999). Probably such 
discrepancy may be explained by more prominent role of genetic factors for primary MDD 
development, whilst in cases of secondary MDD and primary AD diagnosis the 
involvement of environmental and psychogenic factors may be more important especially 
for depression development. 
3. The cerebral locus as cause for psychopathology (with emphasis on 
hemispheric laterality in affective and anxiety disorders) 
The data relevant to local cerebral pathology as possible cause for psychopathological signs, 
unfortunately, are scarce, controversial and have not received yet a proper appraisal. All 
such findings were obtained, as a rule, on neurologically ill patients, but not in persons with 
so-called functional disorders, including major depressions and different anxiety disorders. 
Among neurological diseases more frequently were studied epilepsy, traumatic brain injure, 
cerebral tumors with psychopathological manifestations, Parkinson’s disease, multiple 
sclerosis and stroke. 
In line with main objective of present article the data on affective (depressive) and anxiety 
symptoms are present without concern other psychopathology.   
Numerous data have shown that in patients with stroke the side of damage plays role in 
depression origin, although all findings remain mostly controversial. Thus, in series of trials, 
performed by Robinson (2000) and Robinson & Szetela (1981), Robinson et al. (1984) has 
been shown that in patients with left hemisphere stroke the major depression developed in 
60% with lesion in the frontal region, and in 13% with lesion in posterior region. On the 
contrary, in patients with right hemisphere stroke depression was revealed in 17% lesion in 
posterior region and in none case in anterior region. It implies that patients with left anterior 
lesion have significantly higher probability for major depression development than patients 
with any other lesion location (Robinson, 2000; Robinson et al., 1984). 
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Moreover, the proximity of lesion to the frontal pole in the left hemisphere occurs to 
correlate with severity of depression: the closer the lesion to the frontal pole is located the 
more severe degree of depression is expected. For the right hemisphere strokes such an 
association hasn’t been revealed, and quite the contrary, the closer the lesion is located to 
posterior pole the more severe depression is observed (Robinson, 2000; Robinson & Szetela, 
1981). Such a mirror image relationship between depression and lesion locations seems to 
point to two different depressive syndromes, which perhaps despite their external 
similarity, nevertheless, might have hidden discrepancies in their psychopathological 
symptoms, although this should be proved in a special study.  
 Moreover, these data fairly consist with Geodakian’s paradigm on evolutionary stages of 
any signs development: old and even ancient signs are affined to posterior brain regions and 
right hemisphere, while new (recently acquired) signs have affinity to frontal brain regions 
and left hemisphere (1993). 
Another interesting findings, obtained in studies by Robinson (2000) and Starkstein and 
Robinson (1989) concern the role of family psychiatric history among patients with major 
depression following right hemisphere stroke. Principally, the similar family loading on 
psychiatric disorders in patients with left hemisphere lesions hasn’t been found (Starkstein 
and Robinson,1989).  This might suggest the different vulnerability for depression 
development in patients with left and right hemisphere stroke due genetic factors. Patients 
with depression after right hemisphere stroke seem to be more prone to depression, which 
in evolutionary terms is older and determined rather more by genetic and less environment 
factors than depression in patients with left hemisphere stroke, although an external 
psychopathological similarity should be in both subtypes.  
Data on anxiety states due focal brain lesions are less consistent and were observed less 
frequently. Nevertheless, anxiety is thought to represent the second most prevalent mood 
disorder after depression in stroke patients, and its prevalence is believed to reach 3,5-24% 
of all stroke patients (Starkstein et al., 1990; Astrom, 1996). So-called pure anxiety 
syndromes are thought to occur more frequently in patients with right hemisphere lesions, 
while anxiety with concomitant depression occurs in persons with left hemisphere strokes 
(Astrom, 1996; Castillo et al., 1993; Ghika-Schmid & Bogousslavsky, 2000).  
Data on interictal anxiety in temporal lobe epilepsy (TLE) are more controversial. Thus, 
according to data by Dobrochotova & Bragina (1977) depression frequently prevails in patients 
with right sided foci while in patients with left sided foci, as a rule, more frequently anxiety 
occurs than depression. Here should be stressed that these data were obtained analyzing the 
aura semiotics in patients with epilepsy and cerebral tumors, and in this context these data 
may be not properly comparable with mentioned above findings, since data obtained rather in 
patients with depression or anxiety states in interictal period are required.  
Interestingly, the data by Altshuler et al. (1990) and Perini and Mendius (1984) obtained on 
patients with TLE in interictal period are consistent with mentioned findings. In their study 
anxiety disorders were registered more frequently in patients with left than right-foci epilepsy. 
Similarly, in study by Kalinin and Polyanskiy (2009) the frequency of diagnosis of organic 
anxiety disorder in TLE patients with left-sided focus was 3 fold higher than in patients with 
right-sided focus. On the contrary, in the last subgroup of patients more frequent was the 
diagnosis of organic affective disorder. In other words, in interictal period in patients with 
TLE the right focus activity determines mainly affective disorder (depression), while the left 
focus epileptic activity, conversely, provokes anxiety disorder. 
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In study by Helmstaedter et al. (2004) the inverse correlations between Beck Depression 
Inventory score and verbal learning, verbal recognition and figural learning strictly for left 
lateral temporal lobe epilepsy were obtained, that confirms the significance of foci 
lateralization for depression development. Interestingly, statistically significant correlations 
between Depression score and temporal lobe epilepsy with right foci (irrespective of mesial 
or lateral) and left mesiotemporal lobe epilepsy were absent. It confirms the significance of 
left lateral temporal foci strictly in the development of depression and cognitive impairment 
in cases of neocortical, but not mesiotemporal epilepsy, In other words, the depression 
associated with cognitive impairment origins mostly in persons with neocortical epilepsy 
and left-sided foci only. Nonetheless, depression can also occur in patients with 
mesiotemporal epilepsy but irrespective of the foci lateralization, as has been shown in 
study by Quiske et al. (2000). The authors evaluated the association of MRI-defined 
mesiotemporal sclerosis (MTS) with Beck Depression scores in 60 patients with temporal 
lobe epilepsy. Mean depression score was significantly higher in patients with MTS, 
irrespective of MTS lateralization, and investigators concluded, that depression is a good 
indicator of MTS, but not vice versa. However in such a case the link between depression 
and cognitive deterioration is absent (Quiske et al., 2000).  It implies that depression may 
occur irrespective of side foci in paleocortical epilepsy, but predominantly in case of left-
sided foci in neocortical epilepsy. Obviously, in evolutionary terms depression in patients 
with mesiotemporal epilepsy seems to be older compared with depression in persons with 
neocortical epilepsy.  
From evolutionary point of view these findings are consistent with data on depression in 
stroke patients and stress the significance of left hemisphere lesion (focus) for origin of 
relatively novel depression combined with cognitive deterioration in evolutionary terms. 
Nevertheless, the possibility for depression development in patients with right foci (lesions) 
also couldn’t be excluded, but in such a case so – called evolutionary age of depression 
would be more ancient. In other words, such depression should have earlier age of onset, 
and probably the lack of cognitive impairment than depression associated with left 
hemisphere, although this again should be proved in special trials.  
In summary, the aforementioned data have showed the possibility for neuropsychological 
and evolutionary approach at the same time to anxiety and depression evolvement in 
patients with epilepsy and stroke. Such an approach itself at first glance is not relevant 
enough to comorbidity problems of affective and anxiety disorders at all. Nonetheless, the 
possibility exists to extrapolate such approach on comorbidity issues of anxiety and affective 
disorders too, because certain brain functions a priori must be considered as universal for all 
cerebral disorders and diseases. 
4. Asymmetry in neuropsychological tests for verbal and gestalt function in 
patients with epilepsy 
A great deal of data exists that contradict to traditional knowledge of the role the left and 
right hemispheres in neuropsychological functions processing. Thus, the classical and 
traditional point of view on distribution of cerebral functions asserts the primary role of left 
hemisphere in verbal and analytical functions, and right hemisphere in so-called gestalt 
functions including visual and spatial cognition. Based on this paradigm suggestion can be 
made, that temporal lobe epilepsy (TLE) with left-sided foci should cause strictly damage of 
verbal memory and analytical abilities, while in right-foci TLE an impairment in 
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visuospatial tests should be expected (Lavadas et al., 1979; Mungas et al., 1985;  
Ossetin,1988). 
The findings obtained after selective left- or right temporal lobes had been removed, as a 
whole, confirmed aforementioned paradigm (Milner, 1965). 
This traditional view had steadily existed until the recent years when principally new 
findings were obtained on patients with TLE. Thus, statistically significant relations between 
foci lateralization and impairment of verbal and nonverbal memory have been revealed not 
in all studies (Perrine& Kiolbasa, 1999; Spencer, 1998), that can’t be solely explained by 
traditional paradigm of discrepancies in left- and right hemisphere functions.  Proposed 
explanations usually were based on facts of bilateral temporal lobes involvement in cases of 
mesiobasal epilepsy (Dupont, 2002; Dupont et al., 2002).  In such cases there is no need to 
contrast left- and right foci in patients with TLE, since hippocampal sclerosis is thought to 
cause damage as in the left, as in the right temporal lobe.  
 Nevertheless, the data on differences in capability of left and right hemispheres in 
neuropsychological test performing by patients with TLE have been observed not only in 
epilepsy with hippocampal sclerosis, but in cryptogenic epilepsy too.   
Thus, in study by Moore and Baker (1996) Wechsler tests for evaluating verbal, visual and 
general memory were used in patients with TLE resistant to antiepileptic drugs. The 
patients with left foci performed tests on verbal and logic memory worse, than patients with 
right foci, as should be expected. Nevertheless statistically significant differences in 
nonverbal and visual tests between patients with left and right foci haven’t been obtained. It 
implies that nonverbal and visual functions are determined not only by right hemisphere 
but by left hemisphere too. The similar findings have been also obtained in other studies 
(Barr& Consortium, 1995; Breier et al., 1996). 
Notably, the similar results are observed irrespective of epilepsy form, i.e. as in cryptogenic, 
as in symptomatic temporal lobe epilepsy (Giovagnoli & Avanzini, 1999).  In other words, 
the brain organic lesion itself, including mesiotemporal sclerosis, isn’t enough to explain 
aforementioned discrepancies in hemisphere functions. The left hemisphere seems to be 
responsible as for analytic and verbal, as for gestalt function, while the right hemisphere – 
strictly for gestalt functions. Based on their findings authors concluded that lateralization of 
brain functions concerns strictly the verbal, but not the visual functions (Giovagnoli & 
Avanzini, 1999). 
Concluding this part of article we may suggest that TLE with left foci is more virulent than 
with right foci, because it causes deterioration as in verbal, as in nonverbal functions. In this 
context epilepsy with left foci is quite similar to epilepsy with bilateral foci, and discrimination 
between them based solely on clinical data seems to be difficult. On the other hand, the right-
foci epilepsy seems to be characterized strictly by unilateral damaged functions, determined 
by the right hemisphere. Any adequate explanations for these discrepancies are still 
unfortunately absent, but suggestion can be made that part of left hemisphere functions 
duplicates the properties of right hemisphere in temporal lobe epilepsy.  Obviously, an 
extrapolation from epilepsy model on other pathological states and disorders are probable, 
since brain mechanisms concerning hemispheric laterality function must be universal. 
5. An evolution of brain functions in phylogeny and ontogeny 
Ernst Haeckel, a brilliant German biologist and successor of Charles Darwin, had discovered 
in 19-th century rule, which later has became known under his name as biogenetic law 
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(Haeckel, 1870).  According to this law, the temporal sequence of acquired characteristics in 
ontogeny is quite similar to that in phylogeny in condensed manner. In other words, the 
appearance of any signs, symptoms, disorders, and pathology, at all, during individual life 
repeats its appearance in phylogeny for this species. Based on this rule, the prediction can be 
made, that earlier appearance of signs and disorders in ontogenesis of Homo sapiens reflect 
their earlier origin in evolution while the appearance of any signs in later period of 
individual life points out to the novel evolutionary signs.  
The further development of Haeckel’ law has been made by modern Russian biologist V. 
Geodakian (1993) , who has extrapolated Haeckel’s rule on  brain evolution  taking into 
account the role of cerebral lateralization. 
In line with Geodakian’s rule, the hemispheric lateralization of different cerebral functions 
also points at different time period for their appearance in phylogeny. Thus, the right 
hemisphere is responsible for gestalt analysis, and is regarded as ancient brain function, 
while the left hemisphere, conversely, determines the analytical and verbal processing, that 
are thought to be the novel acquired brain functions (Geodakian, 1993). 
The similar point of view on the cerebral lateralization as indicator of acquired brain 
functions at different stages of evolution of Homo sapiens has been reported by other authors, 
and particularly by British psychiatrist Timothy Crow (1998).    
Taking all these data together, a suggestion can be made, that any characteristics and 
symptoms in neuropsychiatric disorders associated with left hemisphere should be 
regarded as younger in comparison with signs and symptoms associated with right 
hemisphere (Geodakian, 1993; Crow, 1998). In addition, the appearance of right hemisphere 
signs (i.e. syndromes and disorders) in ontogenesis has to occur earlier than appearance of 
signs determined by left hemisphere. Nevertheless, in development of certain cerebral 
disorders the existence of some symptoms and syndromes attributed to left hemisphere is 
thought to imply the earlier existence of similar signs connected to the right hemisphere, 
and data discussed above, as a whole, confirm this hypothesis.  On the other hand, a definite 
functions and signs existed that are attributed strictly to left hemisphere (i.e. analytical and 
verbal functions) but not vice versa. In other words, right hemisphere functions seem to be less 
universal and specific than some functions determined by left hemisphere.  If accept that 
hypothesis, then data on asymmetry in test performance in epileptic patients described in 
previous chapter can simply be explained: the functions of left hemisphere mean not only 
verbal and analytical processing, but visual and dimensional too. On the contrary, the 
functions of right hemisphere seem to be restricted for gestalt analysis. Obviously, the 
mentioned gestalt functions appear earlier in the right hemisphere and later in the left 
hemisphere. This explains why a damage of right hemisphere can cause impairment of gestalt 
processing only, while the damage of left hemisphere leads to impairment of both analytical 
and verbal, and gestalt processing.  At last, if take into account  the psychopathological 
symptoms or syndromes, attributed electively to the left or the right hemisphere, then we may 
presume that existence of some left hemisphere psychopathological signs imply the existence 
of similar signs in the right hemisphere in earlier stage of ontogenesis, but not vice versa. The 
left hemisphere seems to be much more functionally capable, than right hemisphere, although 
this remains a pure speculative suggestion.  
Obviously, localization data also should be considered in evolutionary model along with 
lateralization findings. Here should be reminded a well known scheme, that brain evolution 
has direction from posterior to anterior regions (i.e. from occipital and parietal lobes to 
temporal, and from them to frontal lobes).  Frontal lobes seem to be the youngest regions of 
brain in evolutionary terms. 
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6. Hemispheric and evolutionary hypothesis for comorbidity 
In the previous sections of current article an unequal role of left and right hemispheres in 
certain neuropsychological test has been revealed, and evolutionary approach for 
explanation in asymmetry in test results has been proposed. As has been shown the left 
hemisphere is much more capable in test performing (including not only verbal, but gestalt 
functions too) compared with right hemisphere which functions are restricted entirely to 
gestalt analysis.  
Obviously, the left hemisphere in someway duplicates the functions and properties of right 
hemisphere (which have earlier origin in ontogenesis) and by that posses more functional 
variability, than right hemisphere. If accept this hypothesis and extrapolate that to all 
functions and properties of brain (with emphasis on psychopathological symptoms and 
syndromes), then data on comorbidity between affective and anxiety disorders may be 
explained from proposed above point of view.  
Really, a certain parallelism between neuropsychological tests performing in epileptic 
patients and affective and anxiety symptoms development due isolated cerebral hemisphere 
lesion can be seen, although there are data, that in someway contradict to this paradigm. 
Nevertheless, depression may been evolved due as the right, as the left hemisphere 
involvement, and existence of left hemisphere pathology (either depression, or anxiety) 
implies the previous existence of hemisphere pathology (mostly in the form of depression). 
In other words, the more variable and broad functions of left hemisphere not only in 
neuropsychological tests but a greater variability in all properties is seen. It concerns, 
particularly, affective and anxiety symptoms and syndromes. As has been shown above the 
left hemisphere is involved in depression and anxiety genesis and by that determines 
presumably comorbidity between them. Moreover, an asymmetry in comorbidity levels 
between depression and anxiety may be explained if accept, that pure anxiety syndrome is 
more attributed to left, than right hemisphere, although this rule has been confirmed only in 
several studies (Dobrochotova & Bragina, 1977; Altshuler et al. 1990); Perini and 
Mendius,1984; Kalinin & Polyanskiy, 2009).  Conversely, in cases of isolated involvement of 
the right hemisphere and depression existence the left hemisphere may remain intact. This 
explains more frequent prevalence of depression over anxiety disorders.  All data discussed 
above also could confirm this suggestion.  
 Obviously, the existent data are not enough to accept a hypothesis proposed above entirely. 
Nevertheless, in cases of left hemisphere involvement the concomitant appearance of both 
depression and anxiety has been observed, that is consistent with mentioned hypothesis. 
 On the other hand, the mixed and poorly differentiated depressive and anxiety states were 
registered more frequently in TLE patients with right hemisphere focus. Moreover in such 
TLE patients the so-called alexithymic features in premorbid period are strongly expressed, 
and alexithymia complemented to the right-sided focus seems to be a risk factor for 
depression or anxiety development (Kalinin et al., 2010).   
As phenomenon, anxiety is characterized by higher degree of cognitive processing and 
vigilance in comparison with depression that, in turn, implies the left hemisphere 
involvement in anxiety disorders. Moreover, traditionally anxiety is thought to be divided 
on psychic subtype and somatic subtype, and the former is more attributed to left 
hemisphere, while the somatic anxiety is thought to be attributed to the right hemisphere.  
Several observations confirm this suggestion. Thus, Reiman et al.(1984, 1986) found PET 
abnormalities in the right parahippocampal region in patients with panic disorder. Similarly 
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Fontaine et al. (1990) revealed MRI abnormalities in the right temporal lobe, while Nordahl 
et al.(1990) reported asymmetric blood flow in the parahippocampal gyrus in patients with 
panic disorder, attributed to greater increase on the right side. Taking all these data 
together, conclusion can be made, that involvement of the right temporal lobe or 
parahippocampal region may be important to the development of panic attacks. 
Noteworthy, the panic attacks include also symptoms of depression, and are characterized 
by more pleomorphic psychopathological structure compared with psychic anxiety in GAD. 
 In conclusion, the current evolutionary and neuropsychiatric approach to comorbidity issue 
in psychiatry is seen to remain as pure speculative due the lack a necessary amount of 
evidence based data. Nevertheless, if assumption on unequal frequency of depression and 
anxiety attributed to right and left hemisphere could be proved, then a rule explaining 
comorbidity would be formulated: in cases of primary diagnosis of so-called relatively novel 
in evolutionary terms disorders (attributed to left hemisphere) the greater frequency of 
comorbid disorder is expected, which is older in evolutionary terms. On the contrary, in 
cases of primary diagnosis of relatively old disorder (attributed to right hemisphere) the 
frequency of comorbid novel disorders is probably much less. Certainly, such a rule remains 
pure speculative hypothesis and must be proved or refuted in special studies in the future.    
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